Controlling drug delivery for the application of extended or sustained-release drug products for parenteral administration
New therapeutic agents are constantly being developed in order to treat new and current disease states. Many of these new compounds display a narrower therapeutic range, where the difference in concentrations between effective treatment and toxicity becomes smaller. As a result, controlling drug rel...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20000132 |